Showing results 4726 to 4745 of 19105
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2016 | Danzhi Qing'e (DZQE) activates AMPK pathway and regulates lipid metabolism in a rat model of perimenopausal hyperlipidaemia | Xing, X.; Su, L.; Asare, P.F.; Wang, L.; Li, L.; Liu, E.; Yu, B.; Zhu, Y.; Gao, X.; Fan, G. |
| 2007 | Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian study | Disney, Alexander Patrick Suffe; De, Jersey, Peter; Kirkland, Geoff; Mantha, Murty; Charlesworth, John A.; Gallagher, Martin; Harris, David C.; Gock, Hilton; Mangos, George J.; MacMillan, J.; Liu, Wei; Viswalingam, Ajit |
| 2015 | Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art | Vanhoecke, B.; Bateman, E.; Mayo, B.; Vanlancker, E.; Stringer, A.; Thorpe, D.; Keefe, D. |
| 2010 | Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivo | Fraser, C.; Lousberg, E.; Guerin, L.; Hughes, T.; Brown, M.; Diener, K.; Hayball, J. |
| 2008 | Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications | Hiwase, D.; Saunders, V.; Hewett, D.; Frede, A.; Zrim, S.; Dang, P.; Eadie, L.; To, L.; Vaz de Melo, J.; Kumar, S.; Hughes, T.; White, D. |
| 2009 | Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial | Apperley, J.; Cortes, J.; Kim, D.; Roy, L.; Roboz, G.; Rosti, G.; Bullorsky, E.; Abruzzese, E.; Hochhaus, A.; Heim, D.; De Souza, C.; Larson, R.; Lipton, J.; Khoury, J.; Kim, H.; Sillaber, C.; Hughes, T.; Erben, P.; Tornout, J.; Stone, R. |
| 2009 | Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo | Fraser, C.; Blake, S.; Diener, K.; Lyons, A.; Brown, M.; Hughes, T.; Hayball, J. |
| 2009 | Dasatinib inhibits the secretion of TNF-α following TLR stimulation in vitro and in vivo | Fraser, C.; Lousberg, E.; Kumar, R.; Hughes, T.; Diener, K.; Hayball, J. |
| 2009 | Dasatinib or high-dose Imatinib for chronic-phase chronic myeloid leukemia resistant to Imatinib at a dose of 400 to 600 milligrams daily. Two-year follow-up of a randomized phase 2 study (START-R) | Kantarjian, H.; Pasquini, R.; Levy, V.; Jootar, S.; Holowiecki, J.; Hamerschlak, N.; Hughes, T.; Bleickardt, E.; Dejardin, D.; Cortes, J.; Shah, N. |
| 2013 | Dasatinib targets chronic myeloid leukemia-CD34⁺ progenitors as effectively as it targets mature cells | Hiwase, D.; Saunders, V.; Nievergall, E.; Ross, D.; White, D.; Hughes, T. |
| 2009 | Dasatinib treatment for Philadelphia chromosome-positive Leukemias: practical considerations | Khoury, H.; Guilhot, F.; Hughes, T.; Kim, D.; Cortes, J. |
| 2009 | Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations | Muller, M.; Cortes, J.; Kim, D.; Druker, B.; Erben, P.; Pasquini, R.; Branford, S.; Hughes, T.; Radich, J.; Ploughman, L.; Mukhopadhyay, J.; Hochhaus, A. |
| 2009 | Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value | Hochhaus, A.; Muller, M.; Radich, J.; Branford, S.; Kantarjian, H.; Hanfstein, B.; Rousselot, P.; Kim, D.; Lipton, J.; Bleickhardt, E.; Lambert, A.; Hughes, T. |
| 2018 | Data mining of small RNA-Seq suggests an association between prostate cancer and altered abundance of 5' transfer RNA halves in seminal fluid and prostatic tissues | Dhahbi, J.M.; Atamna, H.; Selth, L.A. |
| 2016 | Data on keratin expression in human cells cultured with Australian native plant extracts | Adams, D.; Shou, Q.; Wohlmuth, H.; Cowin, A. |
| 2016 | Data set demonstrating an absence of touch effects on social orienting in adults | Reece, C.; Ebstein, R.; Cheng, X.; Ng, T.; Schirmer, A. |
| 2005 | David Lester: A prodigious researcher in suicidology | Goldney, R. |
| 2009 | David Paul Hansemann: Chromosomes and the origin of the cancerous features of tumor cells | Bignold, L.; Coghlan, B.; Jersmann, H. |
| 2007 | David Paul von Hansemann: Contributions to oncology: Context, comments and translations | Bignold, L.; Coghlan, B.; Jersmann, H. |
| 2018 | Day case hernia repair: weak evidence or practice gap? | Scarfe, A.; Duncan, J.; Ma, N.; Cameron, A.; Rankin, D.; Karatassas, A.; Fletcher, D.; Watters, D.; Maddern, G. |
